The first objective was to identify factors associated with prolonged hospital stay (PHS: hospitalized >42 weeks postmenstrual age) in extremely premature (EP: born less than or equal to 28 weeks gestation) infants. The second objective was to identify a PHS best-performing benchmark center.
INTRODUCTION
Prolonged hospital stay (PHS) in extremely premature (EP: <28 weeks PMA, postmenstrual age) infants is associated with poor developmental outcome and increased medical costs. [1] [2] [3] [4] Center differences in demographics, treatments, and morbidities for EP infants are well recognized. [5] [6] [7] [8] [9] [10] [11] These factors, in turn, may contribute to variation in likelihood of PHS in EP infants. PHS risk factors amenable to intervention would be targets for initiatives to reduce PHS. 12 Risk factors for PHS can be identified by applying multivariate analysis to a large EP cohort, but some factors related to PHS risk may be unique to a center and would not be apparent through these methods. Identifying best-performing or ''benchmark'' centers, where EP infants have low risk of PHS, and examining their practices could lead to identification of additional interventions that could reduce risk of PHS. Use of simply incidence of PHS would lead to erroneous designation of a benchmark center. [13] [14] [15] Assessment of risk-adjusted odds of PHS, as well as the competing outcome mortality, must be included in selecting a PHS best-performing center. 15, 16 For this investigation, we set two goals: (1) identify factors independent of center associated with PHS, defined as discharge home beyond 42 weeks PMA, for EP infants. These factors would be targets for interventions to reduce PHS, and (2) identify a PHS bestperforming center, with consideration of centers' risk-adjusted odds of PHS and center differences in mortality, for future benchmarking studies that could identify practices to reduce PHS in all centers. We hypothesized that demographic, perinatal, morbidity, and treatment variables would contribute to PHS and identification of a best-performing center would require evaluation of center differences in risk-adjusted odds of PHS and risk-adjusted odds of mortality.
METHODS
We performed a retrospective cohort analysis of infants admitted to NICHD Neonatal Network centers between January 1, 1998 and October 30, 2001 . The Network is a consortium of academic tertiary centers. We utilized information gathered by trained research staff for the Network's Data Registry which includes information on infants with birth weight between 401 and 1500 g admitted to Network centers within the first 14 days of life, or who died in the delivery room. Approval for data collection and analysis was obtained from Institutional Review Boards at each center. Inclusion criteria for this analysis was birth at <28 weeks gestation. Exclusion criteria were diagnosed congenital or chromosomal anomalies. The definition for the primary outcome, PHS, was selected based on evidence, which suggests that the majority of EP infants are discharged by 42 weeks PMA. 15, 17 Birth weight (BW) and chronologic age were not used for inclusion or outcome criteria, respectively, due to potential inclusion bias.
To achieve our first goal of identifying factors associated with PHS, we developed a logistic regression model, which included center and demographic factors, baseline perinatal characteristics, treatments, and morbidities diagnosed during the NICU stay. Factors included in the PHS model were significant at the P<0.1 level in bivariable analyses comparing multiple characteristics and rates for infants with and without PHS. The factors tested were selected from characteristics and events included in the Network Data Registry. Student's t-tests for continuous variables and w 2 or Fisher's exact tests were used in bivariable analyses were appropriate. The reference center for the multivariable analysis of PHS had the lowest unadjusted rate of the combined outcome, PHS or mortality.
To achieve our second goal of identifying a PHS best-performing center we added the assessment of risk-adjusted center differences in mortality odds vs the reference center. Assessing risk-adjusted odds of mortality relative to risk-adjusted odds of PHS would provide insight into whether or not higher center mortality could be related to lower PHS. Using risk-adjusted odds ratios rather than simply frequencies of mortality and PHS would provide some accounting for variation in demographic and baseline characteristics between centers. The reference center in the mortality analysis was the same as that used in the PHS model. Demographic and perinatal factors applicable to survivors and infants who died early in life were included in this model. PHS and mortality logistic regression models included only subjects with complete data for all included variables. Only centers with complete information on at least 80% of enrolled infants for all tested variables were included.
Definitions of terms and diagnoses were standardized by the Network's Manual of Operations. Gestational Age was defined by obstetrical estimates; if no obstetrical estimate was available, a neonatologist's estimate based on physical criteria, was used. Chronic lung disease at 28 days (CLD28) was defined as oxygen use at that time point. Chronic lung disease at 36 weeks postmenstrual age (CLD36) was defined as supplemental oxygen use at that time point, or at the time of discharge home. If the baby was transferred to another nursery prior to 36 weeks postmenstrual age, and information on oxygen use at 36 weeks was unavailable, that infant was not included in the analyses. Late-onset sepsis was defined as a positive blood culture obtained in the presence of compatible clinical signs of septicemia associated with Z5 days of antibiotic treatment after day 3 of life. 18 Intraventricular hemorrhage (IVH) grades III and IV were defined using Papile's criteria. 19 Necrotizing enterocolitis (NEC) was classified according to Bell's criteria modified by Walsh. 20 Retinopathy of Prematurity (ROP) stage IV was defined as any retinal detachment, stage V was total detachment. Postnatal steroid use was defined as any use of systemic steroids to prevent or treat chronic lung disease. H2 blocker use was defined as any use of this therapy.
All data were analyzed using SAS s version 8.02 at RTI International, Research Triangle Park, NC.
RESULTS

Study Cohort
Between January 1998 and October 2001, 7576 EP infants were admitted to one of 15 Network centers and included in Network Registry. Among these, 192 were excluded due to congenital anomalies. Three of 15 network centers had missing information on either PHS or any of the covariables from more than 20% of enrolled infants and were not included in the analyses. A total of 6410 infants from 12 network centers were included in the analysis, including 4336 survivors. The number of Infants with complete information for all tested variables in the multivariable models is included in the description of each of the two outcomes below.
Prolonged Hospital Stay
The cohort for identification of variables associated with PHS and used in the regression model for PHS vs non-PHS included 3892 EP infants (90% of survivors) from 12 centers who met inclusion criteria. The median (range) for length of stay (LOS) in PHS vs non-PHS infants was 142 (99-734) days and 76 (28-133) days, respectively. Overall, 17.6% of EP infants from the 12 Network centers had PHS. Proportion of infants with PHS ranged from 9.5 to 30.9% among the 12 centers. Comparisons of patients with and without PHS revealed differences in multiple demographic, perinatal, treatment, and morbidity variables significant to the P<0.10 level in bivariable analyses that were included in multivariable analysis of PHS.
Additional descriptive analyses revealed that among those with PHS, 64% had neurodevelopmental impairment (NDI), defined as any one of: (a) moderate to severe cerebral palsy, (b) Bayley MDI and/or PDI <70, (c) blindness (no useful vision) in both eyes, or (d) deafness in both ears requiring aids. Of those discharged home before 42 weeks, 35% were diagnosed with NDI. 343 (7.5%) of the 4558 infants in the study cohort were transferred to a secondary facility prior to discharge home. In all, 28 of the transferred infants went to chronic care facilities, and 26 of these had PHS (93%). Of the 325 infants transferred to secondary units other than chronic care facilities, 15% had PHS.
In the PHS logistic regression model, center variation contributed significantly to the risk-adjusted PHS odds (overall P<0.0001). Odds ratios and confidence intervals for each center and additional variables associated with increased PHS odds are provided in Table 1a and b. The variables that were different between PHS and non-PHS at P<0.1 in the bivariable analysis but not in the logistic regression analysis are listed in legend of Table  1a and b.
Mortality
The cohort for identification of variables used in the regression model for mortality vs survival to discharge home included 6365 EP infants from 12 centers included in the PHS analyses. Overall, 28.5% of EP infants from these 12 Network centers died. The proportion of infants who died ranged from 20 to 41.4% among the 12 Network centers. The median age at death was 2 days, with a range of death occurring in the first hour of life to 560 days. The 75th percentile for time to death was 14 days. Odds ratios and confidence intervals for each center and additional variables associated with increased mortality odds are provided in Table 2a and b. As in the analysis of PHS, center contributed to variation in mortality odds (P<0.0001). Birth in 1999 contributed to increased mortality odds vs 1998, the reverse of the trend noted for PHS odds.
Relationship between Mortality and PHS
The center with highest risk-adjusted odds of PHS was one of only three with mortality odds not significantly different than the reference center. The three centers with lowest PHS odds vs the reference center had the three highest mortality odds vs the reference center. When centers' risk-adjusted odds ratios of PHS and mortality are plotted together, PHS odds trend inversely related to odds of mortality (Figure 1 ). This model, which included center and multiple other risk factors, had a maximumrescaled r 2 of 0.50. Noncenter variables significant at the P<0.1 level in bivariate analysis that did not contribute to PHS odds included maternal age, birth outside Network center, gender, 2000 and 2001 vs 1998, black, Hispanic and other races vs white, Apgar score at 5 minutes, prenatal steroids, medical NEC, severe IVH, patent ductus (yes or no), organism-specific infections (Staph, enteric Gram-negative rods, CONS, Candida), days to regain birth weight, and time to first feed. Additional variables tested but not significant at p<0.1 included multiple birth, prenatal care, early onset sepsis, vent days, high-frequency vent days, CLD at 28 days, PDA successfully treated with indomethacin, and PDA successfully treated with surgery.
DISCUSSION
Several risk factors, including center, were associated with PHS odds. A best-performing reference center was identified by analysis of risk-adjusted PHS odds and risk-adjusted mortality odds. Our results reinforce the importance of assessing risk-adjusted odds of both PHS and mortality in selecting a best-performing center.
Various approaches could have been taken with this analysis. Inclusion and primary outcome definitions based on birth weight and chronologic age were previously made using the same study period. In a cohort defined by birth weight less than 1000 g and prolonged hospitalization defined by 120 days, the same risk factors and benchmark center were identified. 21 When the reference value for PHS was defined by the mean incidence of PHS among all centers rather than a reference center's incidence of PHS, center variation remained significant, and the reference center in this study was the only center with reduced PHS odds relative to the mean.
Neonatal morbidities NEC, nosocomial infection and chronic lung disease at 36 weeks contributed to PHS risk. As a result of its high associated mortality, morbidity among survivors and cost, NEC deserves prioritization as a target for both prevention and treatment. 1 Our analysis is in agreement with work associating late onset infection with length of stay. 18, 22, 23 Efforts to reduce infection rates by optimizing current ''standard'' NICU care, as described in previous benchmarking efforts, could reduce odds of PHS. 12, 24 Benchmark centers with low incidence of nosocomial infection can be identified, but the selection process should include consideration of mortality differences between centers. 25 Chronic lung disease may also be reduced by identifying and implementing best practices. 12 In this analysis, as in previous benchmarking studies to reduce CLD in preterm infants, 12 associations between CLD and PHS are limited by defining disease by use of oxygen at 36 weeks. 26 Associations in this retrospective study between treatment and nutrition variables and increased PHS may reflect treatment choices due to illness severity rather than causation. Earlier feeding may reflect that infants fed earlier were less ill and able to tolerate enteral feeding strategies. 27 In previous studies, aggressiveness of early feeds, earlier initiation of feeds, earlier attainment of full feeds and earlier regaining of birthweight have had measurable associations with outcome. [28] [29] [30] Evaluation of nutrition practice in the absence of, or in the recovery phase after, morbidity may reveal practice differences that could lead to improved outcomes including reduced PHS.
The inverse relationship between mortality and PHS is likely due to the fact that most EP deaths occur early, as reflected by our data, Figure 1 . Centers' risk-adjusted odds ratios for PHS and mortality vs the reference center. The reference center, which is not shown on the graph, had the lowest incidence of mortality and PHS. rather than after a defined prolonged hospitalization. Previous studies have demonstrated variation in attitudes 30 and practice 16 regarding resuscitation and prognosis of EP infants in NICU's in the United States and Europe. Results from these studies, as well as work by Vohr et al. 9 , and our results showing a high prevalence of NDI among PHS infants, suggest a trade off of less aggressive early interventions and higher mortality for more aggressive care associated with improved survival with higher risk of neurodevelopmental impairment. Resuscitation and ongoing care variation could be dependent on institutional policy, the level of training of those attending deliveries, individual attending differences during the NICU stay, or family attitudes. This retrospective review is limited in its ability to distinguish how much varying attitudes toward resuscitation and ongoing care vs quality of care contributed to mortality differences among centers.
Results of our analysis found that approximately half of the variability in odds of PHS in this cohort was explained by the variables included in the logistic regression model. Other unmeasured factors could have contributed to the variability. Quantifying illness severity at the time of birth or transfer to the tertiary center could have added predictive value to PHS and mortality. 7 Referral patterns could also have influenced results, as some referral hospitals transfer only vigorous infants to tertiary centers, while others transfer only the sickest infants, leading to differences in outcomes among both receiving and referring centers. 31, 32 Unmeasured variation in obstetric care and attitudes toward viability of extremely premature infants could have contributed to outcome. 33 Nurse staffing levels could also affect outcome. 34 Discharge policies, levels of family involvement, family, and community preparedness for caring for a preterm infant could contribute to variation in PHS. Future research should include analysis of home health resource use and readmission rates. 2, 35, 36 Identifying optimal prevention strategies and treatments for chronic lung disease, surgical NEC, and late onset sepsis could reduce PHS for extremely premature infants, but even after accounting for morbidities in multivariable analyses, center variation in PHS persists. The significant center variation suggests the need for benchmarking studies to identify other factors that affect PHS. Our results identify a strategy for selection of a bestperforming center for PHS benchmarking studies, which includes assessments of centers' risk-adjusted odds of both PHS and the competing outcome, mortality.
